Wed. Nov 25th, 2020

Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others.

Major players operating in preclinical imaging market include:
FUJIFILM Holdings Corporation (Japan), MR Solutions (U.K.), PerkinElmer Inc. (U.S.), Siemens Ltd (U.S.), Miltenyi Biotec (Germany), Aspect Imaging (Canada), MILabs B.V. (Netherlands), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), TriFoil Imaging (U.S.), and Carestream Health (U.S.) to name a few.

Get sample copy of “Preclinical Imaging Market” at: https://www.marketgrowthinsight.com/sample/56315?source=shubh

Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.

The preclinical imaging market has been segmented by type of product, application, and end-user

Based on product type, preclinical imaging market segmented as:
Imaging Modalities
Single Photon emission computed tomography (SPECT)
Micro Computed Tomography (Micro-CT)
Magnetic Particle Imaging
Magnetic Resonance Imaging (MRI)
Optical Imaging
X-Ray Imaging
Positron Emission Tomography (PET)
Ultrasound
Others
Reagents and Kits

Based on of application, preclinical imaging market is segmented as:
Research and Development
Drug Discovery

Based on the end-user, preclinical imaging market is segmented as:
Biotech Companies
Pharmaceutical companies
Research institutes

Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate preclinical imaging market. According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012. Companies adopting product innovations to increase their market share. Currently, the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In-vivo imaging is increased usage in target identification, compound optimization and pre-Phase I study, and in the drug development process. Thus, it bridges the gap between in-vitro exploratory and in-vivo clinical research. Regions such as Latin America, Middle East, and Asia Pacific are witnessing an increase in foreign investments that is leading to greater revenue generation, for the market growth.

Have any query? Inquiry about report at: https://www.marketgrowthinsight.com/inquiry/56315?source=shubh

Research objectives:-

– To study and analyze the global Preclinical Imaging consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Preclinical Imaging market by identifying its various sub-segments.
– Focuses on the key global Preclinical Imaging manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Preclinical Imaging with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Preclinical Imaging Market Size
2.2 Preclinical Imaging Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 Preclinical Imaging Market Size by Manufacturers
3.2 Preclinical Imaging Key Players Head office and Area Served
3.3 Key Players Preclinical Imaging Product/Solution/Service
3.4 Date of Enter into Preclinical Imaging Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Preclinical Imaging Sales by Product
4.2 Global Preclinical Imaging Revenue by Product
4.3 Preclinical Imaging Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Preclinical Imaging Breakdown Data by End User

Get sample copy of “Preclinical Imaging Market” at: https://www.marketgrowthinsight.com/sample/56315?source=shubh

In the end, Preclinical Imaging industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.

About Us-

Market Growth Insight 100% Subsidiary of Exltech Solutions India, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 30000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.

Contact Us-
Email: [email protected]
Phone: + 91 8956767535
Website: https://www.marketgrowthinsight.com

By Exltech